Ukwenza ukhetho olufanele mayelana ne- multiple sclerosis yakho (MS) ukwelashwa kwezidakamizwa kuqala ngokukwazi amaqiniso. Kwezinye izimo, ukukhetha kungalinganiselwe ngenxa yesigaba sesifo sakho, ubunzima bezimpawu, noma noma yiziphi izidakamizwa ezedlule ezidakamizwa okungenzeka wazibonise kuzo.
I-Avonex (i-interferon beta-1a) iyindlela eyodwa ejwayelekile echazwe ezifweni zakuqala. Njengawo yonke imithi ye-MS, inezibili izinzuzo zayo nokungaphumeleli.
Izinkomba
I-Avonex (i-interferon beta-1a) iyisidakamizwa esijoqayo esinikeza isilinganiso esincane kakhulu se-interferon uma kuqhathaniswa nezinye izinketho zokwelapha. Kwamukelwa yi-US Food Administration and Drug Administration ngo-1996 ukuze kusetshenziswe kubantu abanezifo ezisenesikhathi esisha-ezaziwa ngokuthi i-MS yokubuyiselwa kabusha (noma i-RRMS) - noma kulabo abaye babhekana nokuhlaselwa kwe-MS kodwa abahlangabezane ne- diagnostic criteria ye-MS .
Ukuphumelela
Ngokombono wezibalo, zonke izidakamizwa okuthiwa i-CRAB (i- Copaxone , Rebif , Avonex, Betaseron ) zihle kakhulu ngendlela ephumelelayo, ukunciphisa ingozi yokuphindaphinda kubantu abane-RRMS cishe ingxenye yesithathu.
Ukucwaninga komtholampilo wangaphambi kwemakethe kuboniswe ukuthi i-Avonex inganciphisa ingozi ye-MS iphinda ibuyele ngamaphesenti angu-32 kubantu abano-RRMS abamnene kuya kuyingxenye. Ezinye izifundo ezithunyelwe emakethe ziye zaphazamisa izidakamizwa phakathi kwamaphesenti angu-19 namaphesenti angu-38, (okungafani nakho okungachazwa ngesikhathi esihlukile socwaningo kanye / noma inani labantu abafundwayo).
I-Avonex ayibonakali engasebenzi kangcono ngokuhamba kwesikhathi.
Kodwa-ke kukhona ubufakazi obuningi bokuthi leyo-interferon ye-high-dose efana neRebif ingase iphumelele nakakhulu kwabanye. Ngakho-ke, i-Rebif ivame ukufakwa njengokwelashwa kwemigqa yesibili uma umuntu ehlangene nokuphindaphindiwe okuningi ku-Avonex.
Ukuphatha
Odokotela abaningi kanye neziguli zikhetha i-Avonex njengokwelashwa kokuqala komugqa ngoba idinga injection eyodwa ngesonto uma iphikisana neyesithathu kuya kweziyisikhombisa edingekayo kwezinye izidakamizwa.
Umthamo we-once-a-week uyanciphisa nemiphumela emibi efana noketshezi, ukuvumela abantu ukuthi badutshule ngoLwesihlanu babuye babuyele emuva ngempelasonto.
Lokhu kwenza u-Avonex abe yisinqumo esikahle kubantu abasebenza isikhathi esigcwele, banakekele izingane ezincane, noma banezinkinga ezikhawulela isikhathi sabo sokuphumula esitholakalayo. Uhlelo lokulandelela lubuye luthinte abantu abangakhululekile ukuzijoca ngokwabo. Esikhundleni salokho, ukuvakashelwa kwamahhovisi okujwayelekile kungenziwa kuhlelwe (okungase kuqinisekiswe ukunamathela kokwelapha okungcono, futhi).
Ngokungafani nezinye izidakamizwa ezithunyelwa ngaphasi (ngaphansi kwesikhumba), i-Avonex kufanele inikwe i- intramuscularly (ngokuvamile ibe yisisindo somthanga). Ohlangothini oluhlangene, kuvele kube nokubomvu okuncane noma ukuvuvukala endaweni yomjovo.
Okufanelekile, umjovo kufanele unikezwe ngosuku olufanayo njalo ngesonto, nakuba kungasondelana nezinsuku eziyisihlanu noma uma kudingekile izinsuku eziyi-10 uma kudingeka.
Okuqhamuka uma udla imishanguzo
Imiphumela emibi ye-Avonex iyafana nezinye izindlela zokwelashwa eziphakathi kwe-interferon futhi ingabonakala ngezibonakaliso ezinjenge-flu, kufaka phakathi:
- Fever
- Ama-Chills
- Ukuphunga
- I-Muscle Aches
- Ukukhathala
Abantu abangamaphesenti angu-61 abamba i-Avonex bazothola lezi zimpawu ezingagcina noma yikuphi amahora angu-24 kuya kwangu-36 ngokwesilinganiso. Eziningi zazo zizonqamula ngokuhamba kwesikhathi, nakuba zingase zihlale ezinyangeni eziyisithupha noma ngaphezulu ezigidini ezihlukahlukene.
Ukucindezeleka kuye kwaphawula nakwezinye, ngokuvamile ngemva kokwelapha isikhathi eside.
Ukucatshangelwa nokuphambana
I-Avonex ayifanele wonke umuntu. Kungase kusetshenziswe ngokuqapha kwabanye abantu noma kugwenywe ngokuphelele kwabanye. Ukucatshangelwa kuhlanganisa:
- Abantu base-Avonex kufanele bahlolwe njalo ukuze bahlole ama-enzyme ebindi. I-Avonex ingabangela ukuphakama kwala ma-enzyme angabangela ukulimala kwesibindi noma ukwehluleka. Abantu abanezifo zesibindi esandulele noma i- cirrhosis kungenzeka ukuthi bangabi abafanelekile kwi-Avonex futhi kufanele bahlolwe ngesimo-by-case basis.
- I-Avonex akufanele futhi isetshenziswe ngabesifazane abakhulelwe noma abahlela ukukhulelwa . Nakuba kungekho cwaningo lomtholampilo olutholakalayo lokuhlola ingozi engase ibe khona emithonjeni, ukukhubazeka kokuzalwa kuye kwaqaphela eziningana zezifundo zesilwane. Ukuncelisa ukubeletha akukwaziswa futhi kuwe ukuthi ukhona (noma usanda kusebenza) i-Avonex.
- I-Avonex kufanele isetshenziswe ngokucophelela kubantu abanokucindezeleka kliniki. Nakuba kungenqatshelwe ukusetshenziselwa ukusetshenziswa (ikakhulukazi njengoba ingozi yokucindezeleka iqhubekela phezulu kubantu abane-MS), iqinisekisa ukuthi kunakekelwa okukhethekile ukuqinisekisa ukuthi izinga lomuntu lomuntu alibheki ngokweqile ukwelashwa.
- Ngokufanayo, i-Avonex kufanele isetshenziswe ngokucophelela kubantu abanezinkinga zokuhlukunyezwa noma izinkinga zenhliziyo njengoba kungase kukhulise noma kuphuthumise lezi zimpawu. Ezimweni ezingavamile, i-Avonex iye yaziwa ngokubangela ukuhlukunyezwa nokushaya kwenhliziyo kubantu abangenawo umlando wangaphambili noma izici eziyingozi zokubeka isimo.
Izindleko zokwelapha
Ububanzi bokuthengwa kwentengo ka-Avonex ngonyaka ka-2017 bungaphezu kuka- $ 6,500 ngenyanga noma cishe u-$ 81,000 ngonyaka. Umshuwalense uhlanganisa ingxenye yezindleko zokwelashwa, nakuba izindleko zekhophi kanye ne-out-of-pocket ngezinye izikhathi zingase zibe nzima kakhulu. Izinhlelo zokusiza iziguli (PAPs) zitholakala ukusiza ukubuyisela izidakamizwa noma usizo lwe-copay kwalokhu kanye nezinye izinhlobo zemithi ehlala njalo.
Ukuze uthole olunye ulwazi, thintana nabaxhumanisi bokusekela ku-Bionex (umkhiqizi wezidakamizwa) ku-800-456-2255 noma vakashela i-AboveMS.com ngolwazi oluthe xaxa.
> Umthombo
> Ukuphathwa Kwezokudla Nezidakamizwa zase-US. " IZINDLELA EZIPHAKATHI ZOKWENZA ULWAZI: i- Avonex (i-interferon beta-1a) ." I-Silver Spring, e-Maryland; ibuyekeziwe ngo-December 2015.